Viet Nam Herbs & Foods JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000VHE7
VND
3,200.00
-1200 (-27.27%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND Million (Micro Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.58

stock-summary
Return on Equity

4.44%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
116,033 Million
(Quarterly Results - Dec 2025)
Net Profit:
2,525 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
6.67%
0%
6.67%
1 Year
0%
0%
0.0%
2 Years
-8.57%
0%
-8.57%
3 Years
-47.54%
0%
-47.54%
4 Years
-73.11%
0%
-73.11%
5 Years
-46.67%
0%
-46.67%

Viet Nam Herbs & Foods JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
32.30%
EBIT Growth (5y)
76.53%
EBIT to Interest (avg)
1.40
Debt to EBITDA (avg)
5.48
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
0.92
Tax Ratio
15.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.69%
ROE (avg)
0.55%

Valuation key factors

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
7.61
EV to EBITDA
6.06
EV to Capital Employed
0.37
EV to Sales
0.35
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.80%
ROE (Latest)
3.95%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 86.13% vs -34.08% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is 424.80% vs -45.79% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "116,032.50",
          "val2": "62,337.90",
          "chgp": "86.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,395.70",
          "val2": "4,050.20",
          "chgp": "82.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4,231.50",
          "val2": "2,138.10",
          "chgp": "97.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,524.80",
          "val2": "481.10",
          "chgp": "424.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "63.70%",
          "val2": "38.10%",
          "chgp": "2.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 22.61% vs 38.70% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 812.37% vs 18.83% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "534,710.70",
          "val2": "436,101.90",
          "chgp": "22.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43,249.30",
          "val2": "15,534.20",
          "chgp": "178.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "14,264.00",
          "val2": "6,790.80",
          "chgp": "110.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "17,642.50",
          "val2": "1,933.70",
          "chgp": "812.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "68.10%",
          "val2": "20.20%",
          "chgp": "4.79%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
116,032.50
62,337.90
86.13%
Operating Profit (PBDIT) excl Other Income
7,395.70
4,050.20
82.60%
Interest
4,231.50
2,138.10
97.91%
Exceptional Items
0.00
0.00
Consolidate Net Profit
2,524.80
481.10
424.80%
Operating Profit Margin (Excl OI)
63.70%
38.10%
2.56%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is 86.13% vs -34.08% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is 424.80% vs -45.79% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
534,710.70
436,101.90
22.61%
Operating Profit (PBDIT) excl Other Income
43,249.30
15,534.20
178.41%
Interest
14,264.00
6,790.80
110.05%
Exceptional Items
0.00
0.00
Consolidate Net Profit
17,642.50
1,933.70
812.37%
Operating Profit Margin (Excl OI)
68.10%
20.20%
4.79%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 22.61% vs 38.70% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 812.37% vs 18.83% in Dec 2024

stock-summaryCompany CV
About Viet Nam Herbs & Foods JSC stock-summary
stock-summary
Viet Nam Herbs & Foods JSC
Pharmaceuticals & Biotechnology
Viet Nam Herbs and Foods JSC is a Vietnam-based company primarily engaged in food manufacturing and processing.
Company Coordinates stock-summary
Company Details
So 277 duong Van Xuan, Xa Ha Mo, Huyen Dan Phuong HANOI None : None
Registrar Details